Head of Biosafety, Non-clinical and Emerging Technologies
| Dyddiad hysbysebu: | 23 Mehefin 2025 |
|---|---|
| Cyflog: | £76,000.00 bob blwyddyn |
| Gwybodaeth ychwanegol am y cyflog: | £76000.00 a year |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 13 Gorffennaf 2025 |
| Lleoliad: | London, E14 4PU |
| Cwmni: | NHS Jobs |
| Math o swydd: | Parhaol |
| Cyfeirnod swydd: | K0015-25-0000 |
Crynodeb
Key responsibilities: Non-clinical toxicology: support for toxicological, genotoxicity, carcinogenicity and reproductive toxicity assessments in the safety of medicines, including in silico modelling to enhance safety evaluations. Biological safety, and sterilisation and decontamination assessment: underpinning both post-market surveillance and clinical investigations for medical devices. Pharmacogenomics for pharmacovigilance: co-ordinate policy on the integration of pharmacogenomics with pharmacovigilance to support personalised medicine, ensuring our approach remains at the forefront of healthcare. Emerging technologies: lead policy on post-market surveillance and risk assessment of diagnostics, as well as emerging and advanced technologies such as nano-enabled medicines and devices, ATMPs (Advanced Therapy Medicinal Products), and synthetic biology products.